跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XCOPRI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
XCOPRI
Authorized
STANDARD
XCOPRI
Endo Operations Ltd.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
985f7066e5033b8e
Company
Endo Operations Ltd.
Type
Standard
Approval Details
Approval Id
985f7066e5033b8e
Drug Approval Canada Name
XCOPRI
Product Name
XCOPRI
Status
Marketed
Status Date
2023-11-20
Original Market Date
2023-11-20
Din
02538768
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX25 CENOBAMATE
Atc Name
n 03 ax 25
Aig Number
0164761006
Company Name
Endo Operations Ltd.
Company Address
1st Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin, Ireland, D04 H9P8
Active Ingredients
CENOBAMATE
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
985f7066e5033b8e
Type
Standard
Back to Health Canada Approvals